Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
van As Jorrit W, van den Berg Henk, van Dalen Elvira C·The Cochrane database of systematic reviews
BACKGROUND: Platinum-based therapy, including cisplatin, carboplatin or oxaliplatin, or a combination of these, is used to treat a variety of paediatric malignancies. Unfortunately, one of the most important adverse effects is the occurrence of hearing loss or ototoxicity. In an effort to prevent this ototoxicity, diff…